When Millennium Pharmaceuticals Inc. nailed down its overseas marketing deal in July 2003 with Ortho Biotech Products LP for the multiple myeloma drug Velcade (approved two months earlier), investors sat up and took notice. (BioWorld Financial Watch) Read More